The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 300.00
Bid: 300.00
Ask: 304.00
Change: 0.00 (0.00%)
Spread: 4.00 (1.333%)
Open: 296.00
High: 304.00
Low: 296.00
Prev. Close: 300.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Director’s Interests in Shares

20 Dec 2023 18:06

RNS Number : 5302X
Fisher (James) & Sons plc
20 December 2023
 

20 December 2023

James Fisher and Sons plc

Notification of Director's Interests in Shares

On 19 December 2023, an award over ordinary shares of 25 pence each in James Fisher and Sons plc (the "Company") was made under the James Fisher and Sons 2021 Long Term Incentive Plan, to the following person discharging managerial responsibilities ("PDMR"):

PDMR

 

Number of shares held under award

Karen Hayzen-Smith

 

62,358

 

No consideration was paid for the grant of the award which is structured as a restricted share award. This award is being granted to replace certain interests held by Karen in connection with her former role and which were forfeited on her joining the Company.

The award will normally vest on the 19 December 2026 subject to the satisfaction of the performance conditions set by the Remuneration Committee of the Company and which are consistent with those attaching to the 2023 LTIP award granted to other eligible participants in June 2023. The following three performance conditions apply to the award:

50 per cent. of the award is subject to a performance condition based on the Company's earnings per share ("EPS") performance over three financial years commencing with the financial year in which the award is granted. None of this element shall vest if the Company's EPS for the 2025 financial year is less than 50 pence. 25 per cent. of this element shall vest if 2025 EPS is 50 pence, rising on a straight-line sliding scale to 100 per cent. vesting of this element if 2025 EPS is at least 62 pence.

30 per cent. of the award is subject to a performance condition comparing the Company's total shareholder return ("TSR") against a comparator group comprising the constituents of the FTSE 250 Index (excluding investment trusts) at the start of the TSR performance period. TSR shall be measured over three years commencing on 6 April 2023. None of this element shall vest if the Company's relative TSR over this period is below the median TSR of the comparator group. 25 per cent. of this element shall vest if the Company's TSR is in line with the median TSR of the comparator group, rising on a straight-line sliding scale to 100 per cent. vesting of this element if TSR is at least upper quartile.

The remaining 20 per cent. of the award is subject to a performance condition based on the Company's return on capital employed ("ROCE") performance over three financial years commencing with the financial year in which the award is granted. None of this element shall vest if the Company's ROCE for the 2025 financial year is less than 10%. 25 per cent. of this element shall vest if 2025 ROCE is 10%, rising on a straight-line sliding scale to 100 per cent. vesting of this element if 2025 ROCE is at least 13%.

The Remuneration Committee retains the discretion to adjust the awards at vesting to ensure that all relevant factors are taken into account, including the consideration of any windfall gains.

This announcement, including the notification below, is made in accordance with the requirements of the Market Abuse Regulations. 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Karen Hayzen-Smith

2

Reason for Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

James Fisher and Sons plc

b)

LEI

213800J975E5OYR6S216

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25 pence each in James Fisher and Sons plc

GB0003395000

 

b)

Nature of the transaction

Grant of a restricted share award under the James Fisher and Sons 2021 Long Term Incentive Plan. The award will ordinarily vest on 19 December 2026 subject to the achievement of performance conditions.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

62,358

d)

Aggregated information

- Aggregated volume

- Price

Aggregated information

62,358

Nil

e)

Date of the transaction

19 December 2023

f)

Place of the transaction

Outside a trading venue

 

For further information:

James Fisher and Sons plc

Jean Vernet

 

Chief Executive Officer

 

020 7614 9503

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHTMBPTMTMTBAJ
Date   Source Headline
22nd Mar 20224:35 pmRNSHolding(s) in Company
10th Mar 20227:00 amRNSFull year results for the year ended 31 Dec 21
24th Jan 202210:54 amRNSDirector Declaration
29th Dec 20219:55 amRNSMozambique update
17th Dec 20217:00 amRNSAppointment of non-executive director
15th Dec 20215:36 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20215:22 pmRNSHolding(s) in Company
18th Nov 202110:25 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSSale of James Fisher Testing Services for £5.7m
1st Nov 20215:23 pmRNSDirector/PDMR Shareholding
25th Oct 20217:00 amRNSTrading update
22nd Oct 20218:00 amRNSAppointment of non-executive director
15th Sep 20211:26 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf year results for the 6 months ended 30 Jun 21
1st Jul 20217:00 amRNSSale of Paladin for US$17.3m
29th Jun 20217:00 amRNSCapital Markets Event & Pre Close Trading Update
15th Jun 20213:51 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jun 20214:16 pmRNSDirector/PDMR Shareholding
30th Apr 202111:59 amRNSDirector Declaration
29th Apr 20212:01 pmRNSResult of Annual General Meeting
29th Apr 20217:00 amRNSAGM Trading Statement
20th Apr 20217:00 amRNSAppointment of Chief Financial Officer
13th Apr 202111:32 amRNSWithdrawal of Annual General Meeting Resolution
9th Apr 202110:18 amRNSDirector/PDMR Shareholding
8th Apr 20213:58 pmRNSDirector/PDMR Shareholding
6th Apr 20213:48 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights and Share Capital
29th Mar 20217:00 amRNSDirectorate Change
23rd Mar 202112:58 pmRNSAnnual Report and Notice of AGM posted
19th Mar 20211:17 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSResults for the year ended 31 December 2020
25th Feb 202110:42 amRNSNotification of FY Results Date
25th Jan 20217:00 amRNSAngus Cockburn appointed as Chairman
7th Jan 20217:00 amRNSPost close trading update
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:35 pmRNSPrice Monitoring Extension
15th Dec 202011:18 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Nov 20207:00 amRNSDirector/PDMR Shareholding
9th Nov 20205:25 pmRNSTotal Voting Rights
6th Nov 20207:00 amRNSTrading Update
2nd Nov 20207:00 amRNSTotal Voting Rights
23rd Oct 20209:48 amRNSDirector/PDMR Shareholding
6th Oct 20203:58 pmRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSRoyal Navy contract award
21st Sep 20204:00 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSHalf-year results
24th Jul 202012:00 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSHalf year post close trading update
24th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.